Profit repatriation surges 90% in first seven months of FY25
Profit repatriation reached $1.317 billion between July and January, compared to $694 million in the same period last year; manufacturing sector tops outflows
Medical device shortage worsens as customs blocks shipments over registration delays
Hospitals face critical supply crisis; Drap and customs await government directives on expired exemption on December 31, 2024
DRAP resists move to classify infant formula as food items
The Senate Standing Committee directs DRAP to ensure infant formula ads warn that powdered milk is not a substitute for breast milk
DRAP launches nationwide crackdown on substandard diagnostic chemicals
Regulatory authority orders strict inspections and enforcement to combat illegal imports and unsafe practices in medical diagnostics
Govt bans advertisement of medical products without prior approval
New rules prohibit pharma firms, healthcare providers and media from advertising medicines, medical devices, and alternative remedies without approval from regulatory board
Anaemia costs Pakistan over $3 billion annually in lost productivity: report
Undernutrition costs Pakistan $17 billion annually, with stunting and low birth weight as major contributors, reports Canada-based Nutrition International
U.S. provides $590 million to Moderna for bird flu vaccine development
This funding adds to the $176 million HHS provided last year for late-stage trials of an mRNA vaccine targeting H5N1 avian influenza
Pfizer seeks $75.2 million from SAC insider trading settlement
The dispute arises from SAC’s $602 million SEC settlement over insider trades in Wyeth and Elan by convicted employee Mathew Martoma
Johnson & Johnson closes $14.6 billion transaction for brain disease drugs
The move expands J&J's portfolio with Caplyta, a U.S.-approved treatment for schizophrenia and bipolar disorder, alongside experimental drugs
World Bank rates $300 million national health program as ‘moderately satisfactory’
Nearly 46% of committed funds disbursed as reforms gain momentum
TEXPO Pakistan 2024 kickstarts in Karachi with focus on textile, leather industries
Three-day international exhibition draws hundreds of foreign buyers and exhibitors, aiming to strengthen Pakistan's trade ties and showcase local craftsmanship.
Lucky Core completes acquisition of Pfizer’s Karachi facility, key pharma brands
Acquisition includes notable products like Ponstan and Ansaid along with associated trademarks
Pakistan Petroleum Limited announces significant gas discovery in Sindh
This discovery will help in enhancing the indigenous hydrocarbon supply and mitigating the gas demand in the country
Citi Pharma enters into supply agreement with India’s Murli Krishna PharmaÂ
Murli Krishna Pharma will supply high-quality Active Pharmaceutical Ingredients (APIs) and products exclusively to Citi Pharma in Pakistan
Hoechst Pakistan to acquire products and trademarks from Sanofi affiliates
Board approves strategic acquisition to strengthen product portfolio and market position